MENAZIL Trademark
MENAZIL is a USPTO trademark filed by Newcastle Bioscience, LLC. Status: Pending.
Trademark Facts
| Mark | MENAZIL |
|---|---|
| Serial Number | 99275322 |
| Status | Pending |
| Filing Date | 2025-07-09 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Newcastle Bioscience, LLC |
| Attorney of Record | Joseph I. Hirsch |
| Prosecution Events | 18 |
| Latest Event | PUBO on 2026-03-24 |
Goods & Services
Pharmaceutical preparations used to treat one or more of the following: infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, psychiatric conditions, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive diseases, and respiratory conditions
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-01-01 | Amendment and Mail Process Complete | AMC |
| 2025-12-31 | Response to Office Action | ROA |
| 2025-11-05 | Public Note | PNR |
| 2025-11-05 | Non-Final Action | NFIN |
| 2025-11-01 | XSearch Search Summary | XSS |
| 2025-07-09 | Application | APP |
USPTO Refusals on Record
- indefinite_identification
- standard_loc